Recruiting ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL NCT07342478 Conditions CLL, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +23 more Locations The Center for Cancer and Blood Disorders-Bethesda — Bethesda, Maryland, United States Optum Medical Group (Rhodes) P.C. — Las Vegas, Nevada, United States OSU Comprehensive Cancer Center — Columbus, Ohio, United States UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States View Trial Details
